Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Sickle Cell | 24 | 2004 | 346 | 1.410 |
Why?
|
| Erythroid Precursor Cells | 4 | 1994 | 24 | 0.390 |
Why?
|
| Bone Marrow | 4 | 2004 | 334 | 0.350 |
Why?
|
| Fetal Hemoglobin | 4 | 1994 | 28 | 0.330 |
Why?
|
| Erythrocyte Membrane | 5 | 1997 | 24 | 0.270 |
Why?
|
| Hemoglobin SC Disease | 4 | 1999 | 11 | 0.260 |
Why?
|
| Ca(2+) Mg(2+)-ATPase | 3 | 1990 | 7 | 0.240 |
Why?
|
| Calcium-Transporting ATPases | 3 | 1990 | 40 | 0.240 |
Why?
|
| Primary Myelofibrosis | 1 | 2004 | 52 | 0.210 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 1993 | 13 | 0.200 |
Why?
|
| Splenic Diseases | 2 | 1992 | 31 | 0.190 |
Why?
|
| Hemin | 4 | 1993 | 16 | 0.180 |
Why?
|
| Peroxides | 2 | 1990 | 12 | 0.160 |
Why?
|
| Developmental Disabilities | 2 | 1993 | 747 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1999 | 376 | 0.120 |
Why?
|
| Interleukin-3 | 2 | 1993 | 17 | 0.120 |
Why?
|
| Comprehensive Health Care | 1 | 1995 | 19 | 0.110 |
Why?
|
| Erythropoietin | 3 | 1993 | 110 | 0.110 |
Why?
|
| Interview, Psychological | 1 | 1994 | 107 | 0.100 |
Why?
|
| Hydroxyurea | 1 | 1994 | 87 | 0.100 |
Why?
|
| Globins | 1 | 1992 | 36 | 0.100 |
Why?
|
| Hemoglobinopathies | 1 | 1992 | 17 | 0.100 |
Why?
|
| beta-Thromboglobulin | 1 | 1992 | 4 | 0.100 |
Why?
|
| Spherocytosis, Hereditary | 1 | 1992 | 8 | 0.100 |
Why?
|
| Thromboxanes | 1 | 1992 | 10 | 0.100 |
Why?
|
| Acetylcholinesterase | 2 | 1989 | 26 | 0.100 |
Why?
|
| Friend murine leukemia virus | 1 | 1992 | 1 | 0.090 |
Why?
|
| Electrophoresis, Cellulose Acetate | 1 | 1992 | 3 | 0.090 |
Why?
|
| Hemoglobinometry | 1 | 1992 | 4 | 0.090 |
Why?
|
| DNA | 3 | 1994 | 1683 | 0.090 |
Why?
|
| Epoprostenol | 1 | 1992 | 70 | 0.090 |
Why?
|
| Health Care Costs | 1 | 1995 | 409 | 0.090 |
Why?
|
| Growth Disorders | 1 | 1992 | 224 | 0.090 |
Why?
|
| Priapism | 1 | 1990 | 12 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1994 | 855 | 0.090 |
Why?
|
| Depressive Disorder | 1 | 1994 | 484 | 0.080 |
Why?
|
| Vitamin E Deficiency | 1 | 1990 | 3 | 0.080 |
Why?
|
| Educational Measurement | 1 | 1993 | 333 | 0.080 |
Why?
|
| Ascorbic Acid | 1 | 1990 | 82 | 0.080 |
Why?
|
| Penis | 1 | 1990 | 103 | 0.080 |
Why?
|
| Abdominal Neoplasms | 1 | 1990 | 32 | 0.080 |
Why?
|
| Blood Platelets | 1 | 1992 | 336 | 0.080 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 1990 | 78 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 1 | 1992 | 351 | 0.080 |
Why?
|
| Hydrogen Peroxide | 1 | 1989 | 127 | 0.080 |
Why?
|
| Child | 15 | 2004 | 25882 | 0.080 |
Why?
|
| Plant Oils | 1 | 1989 | 37 | 0.070 |
Why?
|
| Humans | 35 | 2004 | 133811 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 1992 | 1430 | 0.070 |
Why?
|
| Mass Screening | 1 | 1994 | 843 | 0.070 |
Why?
|
| Cholinesterase Inhibitors | 1 | 1989 | 103 | 0.070 |
Why?
|
| Colony-Forming Units Assay | 1 | 1987 | 69 | 0.070 |
Why?
|
| Neutrophils | 1 | 1990 | 362 | 0.070 |
Why?
|
| Polycythemia | 1 | 1987 | 45 | 0.070 |
Why?
|
| Prostanoic Acids | 1 | 1987 | 1 | 0.070 |
Why?
|
| Quinine | 1 | 1987 | 9 | 0.070 |
Why?
|
| Lung Diseases | 2 | 1995 | 407 | 0.070 |
Why?
|
| Erythrocytes, Abnormal | 1 | 1987 | 20 | 0.070 |
Why?
|
| Infarction | 1 | 1987 | 22 | 0.070 |
Why?
|
| Rhabdomyosarcoma | 1 | 1990 | 211 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2004 | 3869 | 0.060 |
Why?
|
| Lipids | 1 | 1990 | 565 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 1992 | 1350 | 0.060 |
Why?
|
| Sepsis | 1 | 1990 | 522 | 0.060 |
Why?
|
| Adolescent | 10 | 2004 | 20610 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 1990 | 573 | 0.060 |
Why?
|
| Fatty Acids | 1 | 1987 | 366 | 0.050 |
Why?
|
| Meperidine | 2 | 1995 | 8 | 0.050 |
Why?
|
| Male | 15 | 2004 | 65939 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2004 | 108 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 1992 | 2177 | 0.050 |
Why?
|
| Erythrocytes | 3 | 1992 | 232 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1993 | 68 | 0.050 |
Why?
|
| Child, Preschool | 6 | 2004 | 14878 | 0.050 |
Why?
|
| Tritium | 2 | 1992 | 166 | 0.050 |
Why?
|
| Hemoglobins | 3 | 1993 | 322 | 0.040 |
Why?
|
| Vasculitis | 2 | 1993 | 49 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 1993 | 1106 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 1999 | 1973 | 0.040 |
Why?
|
| tert-Butylhydroperoxide | 2 | 1990 | 9 | 0.040 |
Why?
|
| Adult | 8 | 2004 | 31823 | 0.040 |
Why?
|
| Autopsy | 3 | 2003 | 118 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 1994 | 1516 | 0.040 |
Why?
|
| Exercise Test | 1 | 1999 | 262 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 1999 | 258 | 0.030 |
Why?
|
| Blood Cells | 1 | 1997 | 55 | 0.030 |
Why?
|
| Blood Proteins | 1 | 1997 | 138 | 0.030 |
Why?
|
| Female | 10 | 2004 | 71840 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 1994 | 3644 | 0.030 |
Why?
|
| Heart Rate | 1 | 1999 | 586 | 0.030 |
Why?
|
| Infant | 3 | 2004 | 13246 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 1992 | 3144 | 0.030 |
Why?
|
| Pain | 3 | 1988 | 475 | 0.030 |
Why?
|
| Episode of Care | 1 | 1995 | 3 | 0.030 |
Why?
|
| Alabama | 1 | 1995 | 47 | 0.030 |
Why?
|
| S Phase | 1 | 1994 | 78 | 0.030 |
Why?
|
| Hemoglobin A | 2 | 1992 | 22 | 0.030 |
Why?
|
| Sampling Studies | 1 | 1994 | 79 | 0.030 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1993 | 18 | 0.030 |
Why?
|
| Electrocardiography | 1 | 1999 | 996 | 0.030 |
Why?
|
| Echocardiography | 1 | 1999 | 1127 | 0.030 |
Why?
|
| Psychomotor Disorders | 1 | 1993 | 29 | 0.030 |
Why?
|
| Self Concept | 1 | 1994 | 164 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1991 | 304 | 0.030 |
Why?
|
| Fatigue | 1 | 1994 | 202 | 0.020 |
Why?
|
| Thalassemia | 2 | 1990 | 11 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1995 | 214 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 1993 | 96 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 1995 | 241 | 0.020 |
Why?
|
| Hepatomegaly | 1 | 1992 | 22 | 0.020 |
Why?
|
| Hemoglobin, Sickle | 1 | 1992 | 20 | 0.020 |
Why?
|
| Thymidine | 1 | 1992 | 55 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1997 | 1075 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1994 | 1041 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 1993 | 182 | 0.020 |
Why?
|
| Splenomegaly | 1 | 1992 | 33 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 1999 | 1068 | 0.020 |
Why?
|
| Spleen | 1 | 1992 | 287 | 0.020 |
Why?
|
| Culture Media | 1 | 1991 | 183 | 0.020 |
Why?
|
| Leucine | 1 | 1992 | 312 | 0.020 |
Why?
|
| Potassium | 1 | 1991 | 278 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1991 | 302 | 0.020 |
Why?
|
| Aspirin | 1 | 1992 | 231 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1994 | 1728 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 1990 | 62 | 0.020 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1990 | 8 | 0.020 |
Why?
|
| Cytochrome c Group | 1 | 1990 | 16 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 1990 | 61 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 1990 | 57 | 0.020 |
Why?
|
| Granuloma, Foreign-Body | 1 | 1990 | 8 | 0.020 |
Why?
|
| Cell Division | 1 | 1991 | 766 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 1990 | 94 | 0.020 |
Why?
|
| NADP | 1 | 1990 | 55 | 0.020 |
Why?
|
| Prospective Studies | 2 | 1992 | 6602 | 0.020 |
Why?
|
| Riboflavin | 1 | 1990 | 34 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1992 | 296 | 0.020 |
Why?
|
| Vitamin E | 1 | 1990 | 69 | 0.020 |
Why?
|
| Benzene Derivatives | 1 | 1989 | 19 | 0.020 |
Why?
|
| Syndrome | 1 | 1992 | 1175 | 0.020 |
Why?
|
| Superoxides | 1 | 1990 | 132 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 1999 | 5455 | 0.020 |
Why?
|
| Necrosis | 1 | 1990 | 212 | 0.020 |
Why?
|
| Nonoxynol | 1 | 1989 | 1 | 0.020 |
Why?
|
| Octoxynol | 1 | 1989 | 8 | 0.020 |
Why?
|
| Cell Cycle | 1 | 1992 | 624 | 0.020 |
Why?
|
| Detergents | 1 | 1989 | 22 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1991 | 689 | 0.020 |
Why?
|
| Psychometrics | 1 | 1993 | 690 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 1616 | 0.020 |
Why?
|
| Solubility | 1 | 1989 | 140 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 1994 | 2153 | 0.020 |
Why?
|
| Phosphatidylserines | 1 | 1989 | 49 | 0.020 |
Why?
|
| Acute Disease | 1 | 1992 | 1185 | 0.020 |
Why?
|
| Cell Line | 1 | 1993 | 2861 | 0.020 |
Why?
|
| Base Sequence | 1 | 1992 | 3169 | 0.020 |
Why?
|
| Nutritional Status | 1 | 1990 | 324 | 0.020 |
Why?
|
| Radiography | 1 | 1990 | 824 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1992 | 718 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 1989 | 254 | 0.020 |
Why?
|
| Antioxidants | 1 | 1990 | 371 | 0.020 |
Why?
|
| Cyanates | 1 | 1987 | 1 | 0.020 |
Why?
|
| Hemoglobin C Disease | 1 | 1987 | 3 | 0.020 |
Why?
|
| Prevalence | 1 | 1994 | 2639 | 0.020 |
Why?
|
| Iron | 1 | 1990 | 305 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1987 | 96 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 3966 | 0.020 |
Why?
|
| Chloroquine | 1 | 1987 | 32 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 1995 | 1166 | 0.020 |
Why?
|
| Drug Synergism | 1 | 1987 | 239 | 0.020 |
Why?
|
| Calcium | 1 | 1991 | 1100 | 0.020 |
Why?
|
| Cell Separation | 1 | 1987 | 231 | 0.020 |
Why?
|
| Biopsy | 1 | 1990 | 1204 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 1990 | 1312 | 0.020 |
Why?
|
| Hospitalization | 1 | 1995 | 1921 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 1993 | 2029 | 0.020 |
Why?
|
| Azepines | 1 | 1986 | 65 | 0.020 |
Why?
|
| Proteins | 1 | 1991 | 1099 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 1994 | 3107 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1987 | 306 | 0.010 |
Why?
|
| Glutathione Reductase | 1 | 1983 | 13 | 0.010 |
Why?
|
| Sickle Cell Trait | 1 | 1983 | 11 | 0.010 |
Why?
|
| Riboflavin Deficiency | 1 | 1983 | 9 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 1992 | 3739 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2003 | 110 | 0.010 |
Why?
|
| Death, Sudden | 1 | 2003 | 48 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1992 | 2653 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2003 | 325 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 434 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1990 | 1358 | 0.010 |
Why?
|
| Lung | 1 | 1990 | 1573 | 0.010 |
Why?
|
| Cause of Death | 1 | 2003 | 505 | 0.010 |
Why?
|
| Risk Factors | 1 | 1994 | 11166 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1990 | 1783 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1997 | 353 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1995 | 58 | 0.010 |
Why?
|
| Urticaria | 1 | 1995 | 21 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1995 | 109 | 0.010 |
Why?
|
| Chest Pain | 1 | 1995 | 132 | 0.010 |
Why?
|
| Mice | 1 | 1992 | 18936 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 1733 | 0.010 |
Why?
|
| Animals | 2 | 1992 | 36222 | 0.010 |
Why?
|
| Tissue Preservation | 1 | 1993 | 16 | 0.010 |
Why?
|
| Fever | 1 | 1995 | 312 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 255 | 0.010 |
Why?
|
| Erythrocyte Volume | 1 | 1991 | 4 | 0.010 |
Why?
|
| Biological Transport | 1 | 1991 | 367 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1991 | 439 | 0.010 |
Why?
|
| Potassium Channels | 1 | 1991 | 166 | 0.010 |
Why?
|
| Kinetics | 1 | 1991 | 1323 | 0.000 |
Why?
|
| Blotting, Western | 1 | 1991 | 1137 | 0.000 |
Why?
|
| United States | 1 | 2003 | 11760 | 0.000 |
Why?
|
| Middle Aged | 2 | 2003 | 29287 | 0.000 |
Why?
|
| Genotype | 1 | 1993 | 2819 | 0.000 |
Why?
|
| Random Allocation | 1 | 1986 | 445 | 0.000 |
Why?
|
| Aged | 1 | 2003 | 21714 | 0.000 |
Why?
|
| Rats | 1 | 1991 | 3851 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1986 | 1663 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1986 | 1160 | 0.000 |
Why?
|
| Diet | 1 | 1983 | 1191 | 0.000 |
Why?
|
| Time Factors | 1 | 1986 | 6554 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1993 | 17577 | 0.000 |
Why?
|